Biography

Kelly A. Plummer, Ph.D., has over seven years of experience representing clients in the worldwide prosecution of their patent applications in the chemical, pharmaceutical and biotechnology fields. Clients benefit from her advanced training and extensive knowledge of diverse technologies, including medicinal chemistry, drug delivery systems, nucleic acid- and protein-based therapeutics, coating compositions, polymers and consumer products.

Representative Experience

  • Prepared and prosecuted to issuance patent applications relating to antimicrobial coating formulations, biodegradable polymer compositions and synthetic methods for obtaining flavor and fragrance chemicals.
  • Secured patent protection of a nanoparticle drug formulation for a leading pharmaceutical company.

Background and Credentials

Dr. Plummer received her J.D., cum laude, from Chicago-Kent College of Law in 2012. Prior to joining Marshall, Gerstein and Borun, she gained experience as a scientific researcher at a large biotechnology company, where she directed all project activities toward discovery and validation of novel drug targets for oncology indications.

Dr. Plummer earned her Ph.D. in chemistry from Harvard University. She also holds a B.S. in chemistry (with high distinction) and a B.S. in mathematics (with high distinction), from the University of Minnesota.

During her studies, she earned a National Defense Science and Engineering Graduate (NDSEG) Fellowship and the Beckman Scholars Award for Research in Chemistry and Biological Sciences.

Education

  • Chicago-Kent College of Law, Illinois Institute of Technology (J.D., cum laude)
  • Harvard University (Ph.D.)
    • Chemistry
  • Harvard University (A.M.)
    • Chemistry
  • University of Minnesota (B.S., with high distinction)
    • Chemistry
  • University of Minnesota (B.S., with high distinction)
    • Mathematics

Bar Admissions

  • U.S. Patent and Trademark Office
  • Illinois

Publications and Presentations

Dr. Plummer’s scientific research publications include the following:

  • Plummer, K.A., Kohler, A.C., Parry, G., Bringmann, P. & Larsen, B.R., “Ubiquitin C-terminal Hydrolase L1 (UCH-L1) Activity is Upregulated in the DU145 Prostate Cancer Cell Line” (poster) Ubiquitin & Signaling Keystone Symposium, Big Sky, Montana, (2007)
  • Plummer, K.A., Carothers, J.M., Yoshimura, M., Szostak, J.W. & Verdine, G.L., “In Vitro Selection of RNA Aptamers Against a Composite Small Molecule-Protein Surface,” Nucleic Acids Res., 33, 5602-5610 (2005)
  • Brezin, E., Byrne, R., Levy, J., Pilgrim, K. & Plummer, K., “A Census of Rational Maps,” Conform. Geom. Dyn. 4, 35-74 (2000)
  • Plummer, K.A. & Forsyth, C.J., "Comprehensive Investigation of the Okadaic Acid Pharmacophore" (poster) Beckman Scholars Symposium, Irvine, California, (1999)